Terns Pharmaceuticals (430.F) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.32
-0.3
-0.28
-0.26

Details

Expected EPS
-0.30185447114999997
Actual EPS
-0.26374600000000004
Surprise EPS
0.04
Surprise Percent
+12.62%

Description

⁨Terns Pharmaceuticals⁩ (⁦430.F⁩) has reported earnings of ⁦-0.26374600000000004⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts